22 hours ago
1
mphillips007
Pulmonx (NASDAQ:LUNG) shares plunged ~41% on Thursday after the lung device maker, with its second-quarter financials, lowered its full-year revenue outlook, prompting Piper Sandler to downgrade the company to Neutral from Overweight.
The Redwood City, California-based MedTech posted a double beat
© FBT Company 2025. All rights are reserved
English (US) ·